Medicenna Therapeutics Corp. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
Medicenna Therapeutics Corp. (MDNAF) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of 1.84 CAD/shares as of 2023-03-31, per its 20-F filed 2023-06-27.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2023-06-27
- 2023-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 1.84 CAD/shares.
- 2022-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 2.00 CAD/shares.
- 2021-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 1.96 CAD/shares.
- 2020-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 1.56 CAD/shares.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2023-03-31 | 1.84 CAD/shares 20-F · filed 2023-06-27 |
| 2022-03-31 | 2.00 CAD/shares 20-F · filed 2023-06-27 |
| 2021-03-31 | 1.96 CAD/shares 20-F · filed 2023-06-27 |
| 2020-03-31 | 1.56 CAD/shares 20-F · filed 2023-06-27 |
| 2019-03-31 | 1.67 CAD/shares 20-F · filed 2022-06-22 |
| 2018-03-31 | 2.11 CAD/shares 40-F · filed 2021-05-28 |